Skip Nav Destination
Letter|
October 25, 2024
COVID-19 in patients with Chronic Lymphocytic Leukemia treated with venetoclax: what is the role of anti-CD20 antibody?
Francesco Autore
Fondazione Policlinico A. Gemelli IRCCS, Rome, Italy
https://orcid.org/0000-0002-7868-7469
Search for other works by this author on:
Candida Vitale
Candida Vitale
Univeristy of Torino, Torino, Italy
Search for other works by this author on:
Alberto Fresa
Alberto Fresa
Hematology-Oncology and Stem-Cell Transplantation Unit, Department of Onco-Hematology and Innovative Diagnostics, Istituto Nazionale Tumori IRCCS - Fondazione "G. Pascale", Naples, Italy
Search for other works by this author on:
Marta Coscia
Marta Coscia
University of Torino, Torino, Italy
Search for other works by this author on:
Livio Trentin, Prof.
Livio Trentin, Prof.
University of Padua, PADOVA, Italy
Search for other works by this author on:
Livio Pagano
Livio Pagano
Hematology, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy, Rome, Italy
Search for other works by this author on:
Luca Laurenti
Luca Laurenti
Fondazione Policlinico Universitario A Gemelli Roma IRCCS, roma, Italy
Search for other works by this author on:
Blood Adv bloodadvances.2024013792.
Article history
Submitted:
May 28, 2024
Revision Received:
September 3, 2024
Accepted:
September 29, 2024
